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ABSTRACT Two distinct thyrotropin (TSH) binding species
have been separated from solubilized porcine thyroid membranes.
Membranes were solubilized with 1% Triton X-100, and the su-
pernatant was recovered-by centrifugation at 105,000 x g. Scatch-
ard analysis of thyrotropin binding to solubilize4 membranes (SM)
yielded a nonlinear plot with K, values for the high and low affinity
components similar to those of intact membranes. Chromatogra-
phy of the SM preparation on concanavalin A-Sepharose 4B re-
sulted in the retention of 10-20% of the binding activity. Upon
elution of the column, a peak of binding material (57% of total
activity) was eluted at 0.3 M a-methyl-D-mannoside. This con-
canavalin A (Con A) bound fraction exhibited a linear Scatchard
plot with a Kd value similar to that of the high affinity component
of the SM. The protein fraction that did not bind to Con A (Con
A unbound) also exhibited a linear Scatchard plot, but with affinity
similar to that of the low affinity component of SM. Discontinuous
sucrose density gradient ultracentrifugation revealed the pres-
ence of two major binding peaks in the solubilized membrane
preparation. The slowly sedimenting peak corresponded to that
seen in the ConAbound fraction, whereas the rapidly sedimenting
peak corresponded to that of the Con A unbound fraction. Seph-
arose 6B chromatography indicated that in the case of the Con A
unbound fraction, a single peak of specific binding activity was
eluted in the void volume, and in the case of the Con A bound frac-
tion, one major peak with an approximate Stokes radius of 67 A
and several other minor peaks were eluted. These results dem-
onstrate the physical separation of two distinct TSH binding spe-
cies from thyroid membranes and provide further support for the
model of multiple classes of binding sites.
Evidence has accumulated demonstrating that thyrotropin
(TSH) binding to thyroid plasma membranes is not a simple
bimolecular process (for review, see ref. 1). Previous attempts
to describe the interaction of TSH with its receptor by equilib-
rium saturation analysis have yielded nonlinear (concave up-
ward) Scatchard plots (1-3). Examination ofthe kinetics of TSH
binding has shown that the complex binding behavior is best
explained by assuming the existence of two or more classes of
binding sites with different affinities and capacities (1, 3). Char-
acterization of these binding components from human (1) and
porcine (unpublished data) thyroid revealed that they differ in
several aspects, including temperature and pH sensitivity and
thermodynamic properties. Furthermore, in recent studies of
human thyroid neoplasms (4, 5), it has been demonstrated that
the high affinity site is responsible for stimulation of adenylate
cyclase.
The present study demonstrates the separation of two dis-
tinctTSH binding species from solubilized thyroid membranes,
both of which exhibited linear Scatchard plots with different
binding affinities and capacities. The results are discussed in
light of the negative cooperativity model.
MATERIALS AND METHODS
Materials. Purified bovine TSH [40 international units (IU)/
mg], a gift of John G. Pierce of the University of California at
Los Angeles, was iodinated with 125I (Amersham; IM-30) to a
specific radioactivity of 60-90 uCi/,g (1 Ci = 3.7 x 1010
becquerels) by a modification of the lactoperoxidase method
(1). Radiolabeled and radioinert TSH have previously been
shown to have equivalent affinities for binding sites on thyroid
membranes (4). Partially purified TSH (NIH-TSH-09), follicle-
stimulating hormone (FSH) (NIH-FSH-S9), and luteinizing
hormone (LH) (NIH-LH-S18) were a gift of the National Pi-
tuitary Agency (Baltimore, MD). Thytropar (5 IU/ml) was pur-
chased from Armour Pharmaceutical (Scottsdale, AZ). Bio-
Beads SM-2 were purchased from Bio-Rad. All other resins and
chemicals were purchased from Sigma.
Preparation of Solubilized Membranes (SM). Porcine thy-
roids, obtained from a local abattoir, were immediately frozen
in liquid nitrogen and stored at -90°C. Partially purified mem-
branes (PPM) were prepared and solubilized as described (3,
6). PPM (12 mg of protein) were solubilized by incubation in
30 ml of 50 mM Tris acetate, pH 7.4/1% Triton X-100 for 1 hr
at room temperature. The SM were then centrifuged at 105,000
X g for 30 min at 4°C, and the supernatant was incubated with
Bio-Beads SM-2 (0.3 g/ml of supernatant) for 30 min at 4°C.
This procedure reduced the concentration of Triton X-100 to
0.2%. The Bio-Beads were removed by filtration through
cheesecloth. Protein concentrations were measured by a mod-
ification of the Lowry technique that minimized interference
in the color development by Triton X-100 (7).
Binding Assays. (i) Binding of "2I-labeled TSH to thyroid
membranes was performed as described by Powell-Jones et al.
(1). (ii) Binding to SM was measured as described by Cuatre-
casas (8). "2I-Labeled TSH (1-2 x 105 cpm per tube) was in-
Abbreviations: TSH, thyrotropin (thyroid-stimulating hormone); LH,
luteinizing hormone; FSH, follicle-stimulating hormone; IU, interna-
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cubated with SM (==30 tkg per tube) for 1 hr at 220C in a final
volume of 250 1.d of 50 mM Tris acetate (pH 7.4) containing
0.25% bovine serum albumin and 0.02-0.05% Triton X-100.
After incubation, bound TSH was precipitated with polyeth-
ylene glycol (PEG) and separated by filtration on cellulose ace-
tate filters (Millipore EHWP 025000). Nonspecific binding was
determined in the presence of excess unlabeled hormone (0.2
IU/ml). All calculations assumed a Mr of 28,000 for TSH.
Results ofapparent equilibrium studies were analyzed by the
SCATFIT computer program, kindly provided by David Rod-
bard of the National Institutes of Health.
Concanavalin A-Sepharose 4B (Con A-Seph) Chromatog-
raphy. SM (2 mg/ml) and Con A-Seph (0.5 mg/ml) were in-
cubated in a 1:1 ratio (vol/vol) overnight at 40C. This mixture
was then poured into a 28x 0.6 cm column, drained, and
washed with 50 mM Tris acetate, pH 7.4/0.2% Triton X-100
until all of the unbound protein material, as determined by ab-
sorbance at 280 nm, was removed. The material collected in the
pass-through fraction of the column was designated as the "Con
A unbound" or "Con A-U" fraction. The column was then eluted
with 0.0-1.0 M linear gradient of a-methyl-D-mannoside in 50
mM Tris acetate, pH 7.4/0.2% Triton X-100, and the fractions
corresponding to the protein peak that eluted from the column
were pooled, concentrated, and designated the "Con A bound"
or"Con A-B" fraction.
Sepharose 6B Chromatography. A 30 X 1.6 cm column of
Sepharose 6B was poured at 40C and equilibrated with 50 mM
Tris acetate, pH 7.4/0.25% bovine serum albumin/0.2% Triton
X-100. One-milliliter aliquots ofCon A-B and Con A-U fractions
were prelabeled with"2I-labeled TSH (5 X 105 cpm) in the
presence and absence of excess unlabeled TSH and chroma-
tographed separately on the same column. Aliquots (0.25 ml)
of the resulting fractions were precipitated with PEG, and the
radioactivity in the precipitates was determined. Specific bind-
ing was calculated by subtraction of nonspecific binding from
total binding.
Sucrose Density Gradient Ultracentrifugation. Discontin-
uous sucrose density gradients were prepared from 5%, 10%,
20%, and 50% (wt/vol) sucrose in 50 mM Tris acetate, pH 8.1/
1% Triton X-100. Gradients were prepared by layering 1 ml of
each sucrose concentration in a 5.6-ml cellulose nitrate tube at
40C. Samples (1 ml) were layered on top of the gradient and
allowed to stand for 30 min at 4°C before centrifugation in a
Beckman SW 50.1 rotor at 48,000 rpm for 2 hr at 4°C. In another
set of experiments, samples (1 ml) were fractionated on 4-ml
continuous gradients of 5-20% (wt/vol) sucrose in 50 mM Tris
acetate, pH 8.1/1% Triton X-100 by centrifugation in an SW
50.1 rotor at 39,500 rpm for 12 hr at 4°C. Protein markers of
known sedimentation coefficients were analyzed on parallel
gradients. Fractions were collected from the bottom of the
tubes. Aliquots (100,ul) were then assayed for specific binding
of "2I-labeled TSH at a final pH of 7.4.
RESULTS
Binding Properties of SM. PPM from porcine thyroids were
solubilized with 1% Triton X-100, and the SM were recovered
by centrifugation at 105,000 X g for 30 min. This fraction con-
tained "50% of the total TSH binding activity and 50-75% of
the total membrane proteins. Specific binding of "2I-labeled
TSH was not affected by 0.08-0.8% of Triton X-100. Scatchard
analysis (9) of specific TSH binding to SM yielded a curvilinear
plot with Kd (apparent equilibrium dissociation constant) values
for the high and low affinity binding components similar to those
observed in intact membranes (Fig. 1).
Con A-Seph Chromatography. Chromatography of the SM
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FIG. 1. Scatchard plots of specific TSH binding to PPM(e) and SM
(A). PPM (160 mg/ml) and SM (120,ug/ml) were incubated with 125i1
labeled TSH (84 pM) and varying concentrations of unlabeled TSH
(NIH-TSH-09) for 1 hr at 2200 in a final volume of 250 Al of 50 mM
Tris acetate buffer, pH 7.4/0.25% bovine serum albumin. Incubations
with SM also contained 0.02-0.05% Triton X-100. After precipitation
of SM with 250 p1 of 20% PEG, 125I-labeledTSH bound to SM and PPM
was separated from free TSH by filtration. Nonspecific binding was
determined in the presence of excess unlabeled TSH (0.2 IU/ml). Ra-
dioactivity in the filters was counted and specific binding was calcu-
lated by subtracting nonspecific and filter binding.
of the binding activity on the column. Fifty to seventy percent
of the binding activity of SM did not bind to Con A-Seph and
was found in the Con A-U fraction. After elution of the Con A-
Seph column with an a-methyl-D-mannoside gradient, a peak
of TSH binding activity (57% of total activity) was eluted at 0.3
M a-methyl-D-mannoside, and it is referred to as the Con A-
B fraction.
Scatchard analysis of TSH binding to the Con A-U fraction
exhibited a linear plot indicative of a single low affinity binding
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FIG. 2. Scatchard plots of TSH binding to the Con A-U (A) and to
Con A-B fractions (B). Con A-U (0.65 mg/ml) and Con A-B (0.2 mg/
ml) were each incubated with 125I-labeled TSH and the same concen-
trations of unlabeled TSH for 1 hr at 220C, as described for SM prep-
aration in legend of Fig. 1. Note that in B, specific binding was neg-





Biochemistry: Drummond et aL
2204 Biochemistry: Drummond et aL
sistent with that obtained for the low affinity component of the
Scatchard plots of PPM and SM (Fig. 1).
Saturation analysis ofTSH binding to pooled fractions from
the Con A-B peakalso resulted in a linear Scatchard plot (Fig.
2B). Computer analysis by the SCATFIT program showed the
presence of a single, high affinity TSH binding site with an ap-
proximate Kd of 0.2 nM-virtually identical with that observed
in PPM and SM (Fig. 1).
Sucrose Density Gradient Ultracentrifugation. Aliquots of
SM, Con A-B, and Con A-U were subjected to discontinuous
sucrose density gradient centrifugation, and specific binding of
"2I-labeled TSH was measured in each gradient fraction as de-
scribed. As shown in Fig. 3A, the sedimentation profile of spe-
cific TSH binding to SM revealed two major binding species.
The sedimentation profile of the Con A-U component on dis-
continuous sucrose gradient in the presence of 1% Triton X-100
exhibited a major binding peak that corresponded to the heavier
peak of SM preparation, albeit with some contamination from
the low Mr component (Fig. 3B).
Similar analysis of "2I-labeled TSH binding components in
the Con A-B fraction (Fig. 3B) showed the presence of a single
specific binding peak with roughly the same sedimentation rate
as the low Mr peak of the SM preparation. However, when an
aliquot of Con A-B was fractionated on continuous 5-20% su-
crose gradient, a heterogeneous population of binding com-
ponents was detected. Three major specific binding peaks were
measured, one of which corresponded to the binding peak ob-
served on discontinuous sucrose gradients. The other two sed-
imented more slowly. There was no significant difference be-
tween gradients made in 0.2% or 1% Triton X-100 (data not
shown). This latter experiment was repeated twice and similar
peaks were observed.
Sepharose 6B Chromatography. When an aliquot from the
Con A-U fraction was chromatographed on Sepharose 6B col-
umns after binding with "2I-labeled TSH, a major peak of
bound radioactivity (as determined by PEG precipitation)
eluted with the void volume (data not shown), and a free tracer
peak eluted with an approximate Kav = 0.78. When Con A-U
was prelabeled in the presence of excess unlabeled TSH, the
void volume peak was reduced to about 20% of the total bound
radioactivity, whereas the free tracer peak remained essentially
unchanged.
Pooled fractions from the Con A-B peaks were labeled with
"I-labeled TSH in the presence and absence. of excess unla-
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FIG. 3. Sucrose gradient centrifugation of SM (A), ConA-B (A),
and Con A-U (e) fractions. Samples (1 ml) of SM (2 mg of protein per
ml), Con A-B (0.2 mg/ml), and Con A-U (0.65 mg/ml) were applied to
a 5%, 10%, 20%, and 50% (wt/vol) discontinuous sucrose density gra-
dient (pH 8.1), and centrifugation and 126I-labeled TSH (25I-TSH)
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FIG. 4. Gel filtration on Sepharose 6B of Con A-B after binding to
1251I-abeled TSH. Pooled fractions of the Con A-B peak were rechro-
matographed on a 30 x 1.6 cm Sepharose 6B column and specific TSH
binding was determined as described. The migration of protein mark-
ers was monitored by absorbance at 280 nm.
beled TSH and were chromatographed on Sepharose 6B col-
umns. Fractions (0.4 ml) were collected and total binding and
nonspecific TSH binding were assayed by PEG precipitation.
The elution profile of specific binding activity from one exper-
iment is shown in Fig. 4. The 125I-labeled TSH-binding protein
complex was eluted as a major peak with an approximate Ka
= 0.37. Four or five other binding peaks of varying Mr also ap-
peared to be present. Comparison of the Klv value with those
of reference proteins (10) indicated an apparent approximate
Stokes radius of 67 A for the major peak. Assuming that the
receptor is not significantly asymmetrical or of unusual partial
specific volume (8), the Mr ofthe 67-A peak is around 300,000.
These values are similar to those recently reported for the in-
sulin receptor (8, 11).
Properties of TSH Binding Components. Hormone speci-
fwity. Hormone specificity tests revealed that TSH binding to
the high affinity binding species of the Con A-B fraction was
highly specific, showing <0.01% crossreactivity with LH or
FSH (Fig. 5A). In contrast, the low affinity component of the
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FIG. 5. Binding competition of LH and FSH for the binding of
125I-labeled TSH'to Con A-B (A) and Con A-U (B) fractions. Con A-U
(0.65 m1g of protein per ml) and Con A-B (0.2 mg/ml) were incubatedwith 12 I-labeled TSH (84 pM) in the presence of increasing concen-
trations of unlabeled TSH (0), FSH (v), orLH (A) as described in legend
of Fig. 1.
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FIG. 6. Effects of pH on the binding of TSH to SM (A), Con A-B
(A), and Con A-U (e) fractions. Aliquots of each tissue preparation were
incubated with '25I-labeled TSH (84 pM) for 1 hr at 220C over a pH
range of 4.5 to 9.0. After precipitation with PEG, the samples were
filtered and the radioactivity was counted. Each point is the mean of
duplicate determinations.
ity, with 100-fold greater crossreactivity for LH or FSH (Fig.
5B). This is in agreement with previous studies of intact mem-
branes in which the low affinity site exhibited lower hormone
specificity for TSH and higher crossreactivity with other pep-
tide hormones (1).
pH dependency. The effects of pH on the binding of 1"I-la-
beled TSH were determined for the SM preparation and for the
high and low affinity binding components isolated from Con A-
Seph chromatography (Fig. 6). The SM exhibited near maximal
binding over a broad range of pH values, with a slight peak at
pH 6.5. This is in contrast to the intact membranes, which have
previously been shown to exhibit a very distinct maximum at
pH 6.0 (unpublished data). The low affinity species showed a
similar profile to the SM, although the peak is slightly more
pronounced. The high affinity component also showed a broad
peak; however, maximal binding was closer to pH 7.0.
Sensitivity to salts, temperature, or carbohydrate cleavage
enzymes. Binding of "MI-labeled TSH to PPM, SM, and Con A-
Seph bound and unbound fractions was equally inhibited by the
addition of increasing concentrations of MgCl2 (10-150 mM) to
the incubation buffer. However, binding to SM and Con A-
Seph fractions was less sensitive to NaCl inhibition than was
binding to PPM.
All three solubilized preparations exhibited similar patterns
of inhibition of TSH binding with increasing temperatures
(data not shown). Neither neuraminidase nor /B-galactosidase
had any significant effect on lMI-labeled TSH binding to the
Con A-Seph fractions.
DISCUSSION
These results demonstrate that TSH-receptor interaction in SM
is a complex process characterized by nonlinear Scatchard plots
(concave upward). Although initially attributed to the pres-
ence of heterogeneous binding sites (2), Kohn and Winand
(12)-following the lead of DeMeyts et al (13)-proposed that
nonlinear Scatchard plots ofTSH binding result from negatively
cooperative site-site interactions among a homogeneous class
of binding sites. Experimentally, a system is described as ex-
hibiting negative cooperativity when the dissociation of bound
radioactive hormone is accelerated in the presence of excess
unlabeled hormone (13).
While confirming the original observation of accelerated
dissociation by excess unlabeled hormone, we and others
have presented evidence demonstrating that this kinetic crite-
rion-upon which the negative cooperativity model is largely
dependent-inadequately accommodates numerous features of
the nonclassical binding ofinsulin (14), human growth hormone
(15), TSH (3, 4), nerve growth factor (16), and B3-adrenergic ag-
onist (17). We have shown previously that the enhancement of
dissociation of bound "2I-labeled TSH by native hormone is
not a valid demonstration of negative cooperativity because (i)
it was observed in thyroid and nonthyroid plasma membranes
that exhibited both linear and nonlinear Scatchard plots (1, 4);
(ii) the kinetically determined Kd corresponded to a value ob-
tained for the high affinity component of a nonlinear Scatchard
plot rather than for the intrinsic affinity constant predicted by
the negative cooperativity model (3); and (iii) the enhancement
effect was observed not only when site occupancy was increased
by excess native hormone but also under conditions in which
site occupancy was decreased by the addition ofnative hormone
(3). This prompted the return to the original interpretation of
heterogeneous binding sites.
In this study, we present evidence for the physical separation
of two distinct TSH binding components by chromatography
on Con A-Seph columns, thus confirming the heterogeneity of
TSH binding to thyroid plasma membranes. These two com-
ponents (Con A-B and Con A-U) yielded linear Scatchard plots,
with intrinsic Ka values similar to those of the high and low af-
finity TSH binding components observed in intact and solubi-
lized membranes. In addition, both components were clearly
separated by ultracentrifugation on discontinuous sucrose den-
sity gradients and by chromatography on Sepharose 6B. Similar
findings have been reported recently by Herzberg et al. (18),
who showed that concanavalin A (Con A) inhibited only the high
affinity component of insulin binding to erythrocytes, presum-
ably by selective interaction of the lectin with the high affinity
receptor.
The data presented in Fig. 4 demonstrate that the Con A-
Seph bound material consists ofone major (Stokes radius, =67
A) and several minor binding species ofvarying molecular sizes.
Because detergents are required for solubilization ofTSH bind-
ing components, it is expected that the apparent Stokes radii
measured in this study represent those of the binding proteins
plus an unknown quantity of bound detergent (8). When sim-
ilarly solubilized and analyzed, many of the other peptide hor-
mone receptors thus far examined have similar Stokes
radii-ranging between 60 and 72 A (8, 10, 19)-and many are
composed of more than one peptide subunit. For example, Ja-
cobs and Cuatrecasas (11) have reported recently that the in-
sulin receptor-whose Stokes radius is =71 A and Mr is
300,000-is composed of two Mr 135,000 and two Mr 90,000
peptides linked together by disulfide bonds and strong non-
covalent interactions. On the other hand, Waters and Friesen
(19) have reported that the nonprimate growth hormone recep-
tor-whose Stokes radius is 62 A and Mr is 300,000-is a tet-
rameric protein consisting of four Mr 75,000-80,000 peptides
linked together by disulfide bonds. Although elucidation of the
exact structure of the TSH receptor must await further analysis
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(8, 10, 11), it is possible that the major peak observed on con-
tinuous 5-20% sucrose density gradients and on Sepharose 6B
columns represents the native TSH receptor (Mr, 220,000-
300,000) and the other peaks represent proteolytic fragments
ofthe receptor (11, 20). Similar results have been reported pre-
viously by Tate et al. (20), who showed that the solubilized mem-
brane preparation of bovine thyroid has a heterogeneous thy-
rotropin binding population with Mr of 286,000, 160,000,
75,000, and 15,000-30,000.
The Stokes radius, hormone specificity, and binding affinity
data suggest that the high affinity component is the TSH re-
ceptor. Further support for this conclusion has come recently
from studies of TSH binding to human thyroid adenoma and
carcinoma (4, 5), in which it was shown that adenylate cyclase
responds normally to TSH, even though only the high affinity
component is present. A similar conclusion has also been
reached in studies of insulin binding to monocytes of patients
with congenital lipodystrophy (21), in which it was shown that
insulin resistance was correlated with the absence of the high
affinity sites, whereas the low affinity sites remained unchanged.
In conclusion, these results demonstrate that nonlinear
Scatchard plots of TSH binding result from at least two distinct
binding species rather than from negatively cooperative site-site
interactions as previously hypothesized (13). Though it appears
that the high affinity component is the receptor responsible for
adenylate cyclase activation, neither the true identity nor the
physiological role of the low affinity binding component is yet
known. It is possible that the low affinity binding component
represents (i) aggregates of the receptor formed in vivo as a re-
sult of clustering or self-aggregation of the receptor-a phe-
nomenon similar to that recently demonstrated for insulin (22,
23); (ii) TSH-degrading enzymes; (iii) aggregates ofthe receptor
formed as an artifact during solubilization (20); or (iv) a recep-
tor-effector complex (24). The effector could be a component
of the adenylate cyclase system or of some other system that
mediates TSH action by messengers other than cAMP. Previous
studies have suggested that there may be at least two distinct
effects of TSH on thyroid membranes, including stimulation of
ion flux (25) and increase of the turnover of phospholipids (26),
which occur independently of cAMP. However, elucidation of
these functions must await further purification and character-
ization of TSH binding species and studies of their possible
roles in the action ofTSH in a reconstituted system (27).
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